Orion Corporation

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The pharmaceutical division Orion Pharma is present in 26 countries. Orion has been building well-being since 1917 and the core expertise areas in pharmaceutical research are selected target proteins, enzymes and receptors in Central Nervous System Diseases, Cardiology and Critical Care, Urological and Oncological Therapies as well as respiratory diseases. Orion Pharma Businesses: Proprietary products, Generics, OTC, Self-Care and Non-Medicinal products, Biosimilar products, Animal health, Active Pharmaceutical Ingredients (Fermion), Contract manufacturing, Partnering and In- and Out licensingIn addition to the new proprietary products being developed in-house, Orion is very active in generic prescription drugs as well as OTC drugs and self-care products. Many of these products are gained through in-licensing, which plays an important role in Orion's strategy for its Specialty Products business. Besides active in-licensing, Orion provides some of its products for out-licensing, please ask for a separate product list or view the products - section. Fermion